CN Patent

CN108779102A — 用于治疗癌症及相关疾病和病况的氘代化合物及其组合物和方法

Assigned to Niufumu Pharmaceutical Co Ltd · Expires 2018-11-09 · 8y expired

What this patent protects

本发明提供对于治疗癌症或其相关疾病或病症有用的新型化合物，和其药物组合物及制备方法和用途。

USPTO Abstract

本发明提供对于治疗癌症或其相关疾病或病症有用的新型化合物，和其药物组合物及制备方法和用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN108779102A
Jurisdiction
CN
Classification
—
Expires
2018-11-09
Drug substance claim
No
Drug product claim
No
Assignee
Niufumu Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.